Bio-X Weight Loss Center

Bio-X Weight Loss Center operates as a telehealth-focused regenerative medicine practice serving patients throughout Texas, with clinical oversight from Round Rock. Under the direction of Luis Wilmot Jr., MPAS, PA-C, the clinic delivers medically supervised weight loss programs centered on GLP-1 receptor agonist therapy, including both semaglutide and tirzepatide protocols. Wilmot brings physician assistant training with a Master of Physician Assistant Studies credential to his clinical practice, applying evidence-based protocols for metabolic health optimization. The Round Rock-based center structures its programs around remote consultations, allowing Texas residents to access prescription peptide therapy without in-person office visits while maintaining clinical oversight and regular provider communication.

The clinic's weight loss protocols utilize semaglutide and tirzepatide as primary pharmaceutical interventions, both FDA-approved GLP-1 medications that influence appetite regulation and glucose metabolism. Semaglutide programs typically follow weekly injection schedules with dose titration based on individual tolerance and response metrics, while tirzepatide protocols incorporate dual GIP/GLP-1 receptor activity for patients requiring enhanced metabolic intervention. Beyond GLP-1 therapy, Bio-X Weight Loss Center incorporates NAD+ supplementation into treatment plans, administered through IV infusion protocols designed to support cellular energy metabolism during caloric restriction phases. The clinic also provides vitamin B12 injections as adjunctive support for patients experiencing energy deficits during weight reduction phases. Treatment plans combine pharmaceutical intervention with lifestyle modification guidance, though the specific structure of nutritional counseling and exercise protocols varies by individual patient needs and baseline metabolic status.

Luis Wilmot Jr. conducts initial consultations via telehealth platform, performing medical history review, contraindication screening, and baseline health assessment before initiating peptide therapy. His approach involves establishing measurable goals during intake consultations, then adjusting medication dosing and supportive therapies based on patient-reported outcomes and objective weight metrics tracked throughout treatment duration. The clinic's telehealth model eliminates geographic barriers for Texas residents seeking medical weight loss intervention, with prescription fulfillment coordinated through partnered pharmacies and medication shipped directly to patient addresses. Wilmot's clinical decision-making incorporates hormone optimization principles when appropriate, addressing thyroid function, sex hormone balance, and cortisol patterns that may impede weight loss progress in certain patient populations.

Patients beginning treatment at Bio-X Weight Loss Center complete telehealth intake appointments where Wilmot reviews medical history, current medications, previous weight loss attempts, and metabolic health markers. Following clearance for GLP-1 therapy, patients receive detailed injection technique instruction, side effect management protocols, and scheduled follow-up intervals for dose adjustment and progress monitoring. The clinic's communication structure includes provider access for questions regarding medication tolerance, unexpected symptoms, or plateau periods requiring protocol modification. Patients typically engage in monthly check-ins during active weight loss phases, with consultation frequency adjusted based on individual response patterns and clinical stability. The Round Rock center's telehealth infrastructure allows for flexible scheduling that accommodates working professionals and patients with transportation limitations, expanding access to medical weight loss services across Texas metropolitan and rural areas.

Bio-X Weight Loss Center differentiates its service model through exclusive telehealth delivery within Texas, eliminating the need for repeated in-office visits while maintaining clinical supervision standards required for prescription peptide therapy. The clinic's integration of NAD+ IV therapy and B12 supplementation alongside GLP-1 medications addresses the cellular energy demands and micronutrient considerations that accompany significant caloric restriction. With a 4.9-star rating across 164 Google reviews, the Round Rock-based practice has established patient satisfaction metrics that reflect consistent outcomes and responsive provider communication. Wilmot's focus on individualized dosing protocols rather than standardized treatment pathways allows for optimization based on patient-specific tolerance profiles and metabolic responses, adjusting both medication strength and adjunctive therapies throughout the treatment timeline to support sustained weight reduction and metabolic health improvement.